Nutex Health restates Q1 2025: revenue $211.8M, net income $21.2M, diluted EPS $3.33

Nutex Health Inc.

2025-Q3 EPS reported $8.87 revenue$723,578,000

Total revenue $211.8M, up 214% YoY from $67.5M.
Net income attributable to Nutex $21.2M vs net loss $0.4M in Q1 2024.
Diluted EPS $3.33 vs loss per share $0.08.
Adjusted EBITDA $72.8M vs $(0.4)M prior year.
Net cash from operating activities of $51.0M for Q1 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.